Family Guidance Association of Ethiopia, North West Branch.
Bahir Dar University.
Ethiop J Health Sci. 2021 Jan;31(1):189-200. doi: 10.4314/ejhs.v31i1.21.
Cervical cancer remains the most common cancer of women worldwide. Its burden is more serious in developing countries. It is also the second common cancer deaths of women in Ethiopia followed by breast cancer. The aim of this study was to determine the pooled prevalence and associated factors of precancerous cervical lesions among women in Ethiopia.
We systematically searched published and unpublished articles reported from 2010 to 2019 using a comprehensive search of electronic databases including PubMed and Google scholar for grey literature from August 1 to September 1, 2019. The methodological qualities of included studies were evaluated using Joanna Briggs Institute meta-analysis of Statistics Assessment. The pooled prevalence estimate was calculated using MedCalc software-version 19.0.7, and the pooled odd ratios for predictors was calculated using RevMan software version 5.3.
The pooled prevalence of precancerous cervical lesions among women in Ethiopia was 13.4% (95% CI:10.63% 16.37%). Statistically significant heterogeneity between studies was detected (I=83.1%, P < 0.001). Among all measured associated factors: numbers of women life time sexual partners > 1, OR=2.5 (95% CI:3.70,4.76), being HIV positive women, OR=2.4 (95% CI:1.33,4.61) and women having history of STI, OR=2.0 (95% CI:1.02,3.87) had statistically significant association with precancerous cervical lesions among women in Ethiopia.
The pooled prevalence of precancerous cervical lesions among women in Ethiopia was high as compared to the 5-year worldwide cervical cancer prevalence. Women having more than one life time sexual partners, being HIV positive women and women having history of STI had a statistically significant association with precancerous cervical lesions.
宫颈癌仍然是全球女性最常见的癌症。在发展中国家,其负担更为严重。它也是埃塞俄比亚女性第二常见的癌症死亡原因,仅次于乳腺癌。本研究旨在确定埃塞俄比亚女性癌前宫颈病变的汇总患病率及相关因素。
我们系统地检索了 2010 年至 2019 年发表和未发表的文章,使用全面的电子数据库搜索,包括 PubMed 和 Google Scholar,以获取 2019 年 8 月 1 日至 9 月 1 日的灰色文献。使用 Joanna Briggs 研究所的统计评估方法对纳入研究的方法学质量进行了评估。使用 MedCalc 软件版本 19.0.7 计算汇总患病率估计值,使用 RevMan 软件版本 5.3 计算预测因子的汇总优势比。
埃塞俄比亚女性癌前宫颈病变的汇总患病率为 13.4%(95%CI:10.63%16.37%)。研究之间存在统计学显著的异质性(I=83.1%,P<0.001)。在所有测量的相关因素中:女性一生中性伴侣人数>1,OR=2.5(95%CI:3.70,4.76),HIV 阳性女性,OR=2.4(95%CI:1.33,4.61)和患有性传播感染史的女性,OR=2.0(95%CI:1.02,3.87)与埃塞俄比亚女性的癌前宫颈病变有统计学显著关联。
与全球 5 年宫颈癌患病率相比,埃塞俄比亚女性癌前宫颈病变的汇总患病率较高。一生中性伴侣人数较多、HIV 阳性女性和患有性传播感染史的女性与癌前宫颈病变有统计学显著关联。